Comparing methods to combine functional loss and mortality in clinical trials for amyotrophic lateral sclerosis

Ruben PA van Eijk1 Department of Neurology, University Medical Center Utrecht, Utrecht, the Netherlands

Marinus JC Eijkemans2 Department of Biostatistics, University Medical Center Utrecht, Utrecht, the Netherlands

Dimitris Rizopoulos3 Department of Biostatistics, Erasmus University Medical Center, Rotterdam, the Netherlands

Leonard H van den Berg1 Department of Neurology, University Medical Center Utrecht, Utrecht, the NetherlandsCorrespondence[email protected]

Stavros Nikolakopoulos2 Department of Biostatistics, University Medical Center Utrecht, Utrecht, the Netherlands

Pages 333-341 | Published online: 19 Mar 2018

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

HealyBCSchoenfeldDComparison of analysis approaches for phase III clinical trials in amyotrophic lateral sclerosisMuscle Nerve201246450651122987690
PubMed Web of Science ®Google Scholar
BerryJDCudkowiczMENew considerations in the design of clinical trials for amyotrophic lateral sclerosisClin Investig (Lond)201111013751389
Google Scholar
MillerRGMooreDHALS trial design: expectation and realityAmyotroph Lateral Scler Other Motor Neuron Disord20045suppl 1525415512873
PubMed Web of Science ®Google Scholar
RutkoveSBClinical measures of disease progression in amyotrophic lateral sclerosisNeurotherapeutics201512238439325582382
PubMed Web of Science ®Google Scholar
ShefnerJMDesigning clinical trials in amyotrophic lateral sclerosisPhys Med Rehabil Clin N Am2008193495508ix18625412
PubMed Web of Science ®Google Scholar
GordonPHChengBMontesJDoorishCAlbertSMMitsumotoHOutcome measures for early phase clinical trialsAmyotroph Lateral Scler20078527027317852017
PubMed Web of Science ®Google Scholar
GordonPHCorciaPLacomblezLDefining survival as an outcome measure in amyotrophic lateral sclerosisArch Neurol200966675876119506136
PubMedGoogle Scholar
SimonNGTurnerMRVucicSQuantifying disease progression in amyotrophic lateral sclerosisAnn Neurol201476564365725223628
PubMed Web of Science ®Google Scholar
GordonPHMeiningerVHow can we improve clinical trials in amyotrophic lateral sclerosis?Nat Rev Neurol201171165065421947135
PubMed Web of Science ®Google Scholar
BerryJDMillerRMooreDHThe combined assessment of function and survival (CAFS): a new endpoint for ALS clinical trialsAmyotroph Lateral Scler Frontotemporal Degener201314316216823323713
PubMed Web of Science ®Google Scholar
CudkowiczMEvan den BergLHShefnerJMEMPOWER InvestigatorsDexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trialLancet Neurol201312111059106724067398
PubMed Web of Science ®Google Scholar
MeiningerVGengeAvan den BergLHNOG112264 Study GroupSafety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trialLancet Neurol201716320821628139349
PubMed Web of Science ®Google Scholar
LacomblezLBensimonGLeighPNGuilletPMeiningerVDose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group IILancet19963479013142514318676624
PubMed Web of Science ®Google Scholar
RizopoulosDJoint Models for Longitudinal and Time-to-Event Data: With Applications in RBoca RatonCRC Press2012
Google Scholar
Group UK-LSMorrisonKEDhariwalSLithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trialLancet Neurol201312433934523453347
PubMed Web of Science ®Google Scholar
AggarwalSPZinmanLSimpsonENortheast and Canadian Amyotrophic Lateral Sclerosis ConsortiaSafety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trialLancet Neurol20109548148820363190
PubMed Web of Science ®Google Scholar
AtassiNBerryJShuiAThe PRO-ACT database: design, initial analyses, and predictive featuresNeurology201483191719172525298304
PubMed Web of Science ®Google Scholar
HommelGA stagewise rejective multiple test procedure based on a modified Bonferroni testBiometrika1988752383386
Web of Science ®Google Scholar
IbrahimJGChuHChenLMBasic concepts and methods for joint models of longitudinal and survival dataJ Clin Oncol201028162796280120439643
PubMed Web of Science ®Google Scholar
FinkelsteinDMSchoenfeldDACombining mortality and longitudinal measures in clinical trialsStat Med199918111341135410399200
PubMed Web of Science ®Google Scholar
van EijkRPAEijkemansMJCFergusonTANikolakopoulosSVeldinkJHvan den BergLHMonitoring disease progression with plasma creatinine in amyotrophic lateral sclerosis clinical trialsJ Neurol Neurosurg Psychiatry201789215616129084868
PubMed Web of Science ®Google Scholar
ChenLMIbrahimJGChuHSample size and power determination in joint modeling of longitudinal and survival dataStat Med201130182295230921590793
PubMed Web of Science ®Google Scholar
GordonPHChengBSalachasFProgression in ALS is not linear but is curvilinearJ Neurol2010257101713171720532545
PubMed Web of Science ®Google Scholar
BeghiEChioAInghilleriMA randomized controlled trial of recombinant interferon beta-1a in ALS. Italian Amyotrophic Lateral Sclerosis study groupNeurology200054246947410668716
PubMed Web of Science ®Google Scholar
BeghiEPupilloEBonitoVItalian ALS Study GroupRandomized double-blind placebo-controlled trial of acetyl-L-carnitine for ALSAmyotroph Lateral Scler Frontotemporal Degener2013145–639740523421600
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Comparing methods to combine functional loss and mortality in clinical trials for amyotrophic lateral sclerosis

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Comparing methods to combine functional loss and mortality in clinical trials for amyotrophic lateral sclerosis

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date